Avid Bioservices Inc (CDMO)

[PhoenixRising]

Okay, so no questions about expanding Avid facilities(that I could find)with production revs about the same $5.5 million, but what strikes me is the burn rate. It was expected to rise but at $11 million per quarter with current programs running how much more will they need IF they expand to dozens of potential studies, et al? Avid revs have not increased YOY to any great extent so extrapolated cash burn(only a guesstimate) of $44 million is getting up there/Paul Lytle did state they had cash on hand (73 million) to last a year. I don't think between now and the coming year that will be sufficient. Cash from outside sources would help. The upcoming collaborations for pre-clinical,etc. will cost PPHM,IMO. It was proven last quarter with "...we saw an expected increase in our net loss this quarter..."(Paul Lytle) from SUNRISE trial advancement and as far as I can tell hopefully a third of patients have been enrolled. Money,Money,Money. Sadly, it is always about the money. IMO PR